Acro Biomedical (ACBM) EBIT Growth (3y) (2019 - 2025)
Acro Biomedical (ACBM) EBIT Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 83.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83.91% |
| Sep 30, 2025 | 69.38% |
| Jun 30, 2025 | 84.95% |
| Mar 31, 2025 | 86.85% |
| Dec 31, 2024 | 26.10% |
| Sep 30, 2024 | 85.51% |
| Jun 30, 2024 | 77.46% |
| Mar 31, 2024 | 43.47% |
| Sep 30, 2023 | -181.08% |
| Jun 30, 2023 | -270.59% |
| Mar 31, 2023 | -271.06% |
| Dec 31, 2022 | -273.61% |
| Sep 30, 2022 | -296.26% |
| Jun 30, 2022 | -288.62% |
| Mar 31, 2022 | -163.49% |
| Dec 31, 2021 | -244.49% |
| Sep 30, 2021 | -173.98% |
| Jun 30, 2021 | -86.64% |
| Mar 31, 2021 | -37.18% |
| Sep 30, 2020 | -56.20% |